Menu
Washingtoner
  • Home
  • Financial
  • Home
  • Construction
  • Information Technology
  • Business
  • Marketing
  • Non-profit
  • Education
Washingtoner

Juventix Regenerative Medical PRP Highlighted in University-Published Research Study
Washingtoner/10277008

Trending...
  • City of Tacoma Secures Over $4 Million in Transportation Improvement Board Grants
  • TBM Council Appoints Four Distinguished Leaders to Board of Directors
  • Spokane: Council Members Official Swearing In Ceremony
Laboratory Testing for Product Validation BSR Labs Juventix PRP Study Table Juventix Packaging With Tubes Juventix Regenerative Medical, LLC
TAMPA, Fla. - Washingtoner -- Juventix Regenerative Medical, a leader in regenerative medicine solutions, proudly announces that its Platelet-Rich Plasma (PRP) technology has been featured in a groundbreaking university-published research study. The study, titled "Platelet-Rich Plasma for Rheumatoid Arthritis: A Case Series", published in the peer-reviewed journal Cureus, underscores the efficacy of Juventix PRP in managing rheumatoid arthritis, showcasing its transformative potential in clinical applications.

The study explores the use of PRP to address inflammation and improve outcomes in rheumatoid arthritis patients, with findings demonstrating measurable benefits attributed to Juventix PRP's advanced process. The research highlights the role of PRP in promoting tissue repair and reducing joint pain, offering a promising non-surgical alternative for patients seeking regenerative therapies.

Scientific Validation Backed by Laboratory Studies
Juventix PRP's inclusion in this research aligns with findings from extensive laboratory evaluations conducted by BioSciences Research Associates (2020) and Biofyl Scientific Research (2023). Key results include:
  • 84% platelet recovery, significantly enhancing platelet-derived growth factor (PDGF) concentrations.
  • 10x increase in PDGF levels, with treated PRP reaching 10,844 pg/mL compared to 1,536 pg/mL in untreated samples.
  • Minimal contamination of red and white blood cells, ensuring safety and reducing inflammatory risks.
  • Optimized pH of 7.5, creating an ideal environment for platelet activation and growth factor release.
  • Innovative activation methods, including photoactivation and bio-incubation, transforming PRP into PRF for versatile clinical applications.
"The inclusion of Juventix PRP in a peer-reviewed study underscores our commitment to delivering scientifically validated, high-quality regenerative solutions," said Lance Liberti, CEO of Juventix Regenerative Medical. "Our focus on innovation ensures practitioners can trust Juventix PRP for consistent, superior patient outcomes."

More on Washingtoner
  • $6.4 Million Purchase of Construction Vehicles Plus New Dealership Agreement with Cycle & Carriage for Heavy Equipment Provider to Singapore Region
  • CCHR Says Mounting Evidence of Persistent Sexual Dysfunction From Antidepressants Demands FDA Action
  • Acmeware and Avo Partner to Bring Real-Time Data Integration to MEDITECH Customers
  • New Analysis Reveals Most Patients Discontinue Weight Loss Drugs Within First Year
  • ICHRRF welcomes Sanjaya Sarpong-Kumankumah as Director of Outreach for African Traditional Religions

Special Offer for Medical Practitioners
To introduce clinicians to its cutting-edge PRP systems, Juventix is offering a sample PRP kit for only $20. This limited-time opportunity enables practitioners to experience the proven quality of Juventix PRP firsthand.
• Email: hello@juventix.com with the subject line "SAMPLE"
• Visit: https://juventix.com/sample-page/

About Juventix Regenerative Medical, LLC
Founded in 2017 by Lance Liberti, Juventix Regenerative Medical has been a pioneer in non-surgical regenerative solutions, including FDA-cleared PRP kits. The company offers comprehensive products such as centrifuges, LED activators, and bio-incubators to support superior PRP preparation. Juventix also collaborates with prestigious organizations, including the University of South Florida (USF) Health Center for Advanced Medical Learning and Simulation (CAMLS), to host advanced clinical training symposiums.

For more information, visit www.Juventix.com or contact:
📞 (866) 693-4777

More on Washingtoner
  • Erik Kalasunas Joins ICHRRF As Director of Communications
  • Spokane: Council Members Official Swearing In Ceremony
  • International Law Group Expands Emergency Immigration Consultations for Somali Minnesotans Amid ICE Actions
  • Spokane: Male In Custody After Domestic Violence Court Order Service Results In Emergent Entry Into A Residence; Multiple Firearms Recovered
  • Sergio C. Flores Appointed Tacoma Municipal Court Judge

✉️ Email:
hello@juventix.com
Restore, Revive, Regenerate – Juventix Regenerative Medical.

Media Contact
Lance Liberti
***@juventix.com
866-693-4777


Source: Juventix Regenerative Medical, LLC

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • $1 Million Share Repurchase Signals Confidence as Off The Hook YS Scales a Tech-Driven Platform in the $57 Billion U.S. Marine Market
  • Trends Journal's Top Trends of 2026
  • CollabWait to Launch Innovative Waitlist Management Platform for Behavioral Health Services
  • Urban Bush Women Celebrates Bessie Award Nominations & Winter 2026 Touring
  • Imagen Golf Launches "Precision Lessons" with Trackman iO in Newtown, PA
  • New Report Reveals Surprising Trends in Illinois Airport Accidents
  • PebblePad Acquires myday to Deliver Unified Digital Campus Experiences for Student Success
  • Adam Clermont Releases New Book – Profit Before People: When Corporations Knew It Was Dangerous and Sold It Anyway
  • 30 Community Art Projects Funded by the Tacoma Arts Commission
  • Dirty Heads, 311, Tropidelic, and The Movement to Headline Everwild Music Festival in 2026 with its largest lineup to date!
  • The Stork Foundation Announces 2025 Year-End Impact and Grant Awards Amid Rising National Demand
  • Stout Industrial Technology Appoints Paul Bonnett as Chief Executive Officer
  • Revenue Optics Appoints Ljupco Icevski as Executive Advisor in Strategic Move to Accelerate Commercial Development
  • Waarom brand mentions in ChatGPT steeds belangrijker worden
  • Tacoma: City Council Approves 0.1% Criminal Justice Sales & Use Tax to Enhance Community Safety and Support Vital Services
  • Tacoma: District 5 Council Member Joe Bushnell to Serve as Deputy Mayor in 2026
  • City of Tacoma Secures Over $4 Million in Transportation Improvement Board Grants
  • Sandesh Sadalge Sworn in as District 4 Tacoma City Council Member for First Full Term
  • Tacoma: District 2 Council Member Sarah Rumbaugh Begins Second Term
  • Latasha Palmer Begins Serving as Tacoma City Council Member, At-Large Position 6
_catLbl0 _catLbl1

Popular on Washingtoner

  • City of Spokane Seeks Applicants for Park Board - 177
  • Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026 - 141
  • Spokane Police Department and SPD Cadets Engage with the Logan Community to Discuss Crime Prevention in the Neighborhood - 119
  • Spokane: Flags to be Lowered for Trooper Killed in Line of Duty
  • UK Financial Ltd Board of Directors Establishes Official News Distribution Framework and Issues Governance Decision on Official Telegram Channels
  • South Spokane Standoff Ends Peacefully After Suspect Surrenders to Officers
  • Spokane: Simple Police Contact for a Civil Bike Infraction Ends in Arrest After Suspect Flees from Officers; Stolen Property Recovered After Suspect is Taken into Custody
  • Tacoma: Homicide Investigation – 3500 block of E Grandview Ave
  • From MelaMed Wellness to Calmly Rooted: A New Chapter in Functional Wellness
  • RollCraft Launches Pre-Roll Automation Machines for Producers Scaling Production in 2026

Similar on Washingtoner

  • CCHR Says Mounting Evidence of Persistent Sexual Dysfunction From Antidepressants Demands FDA Action
  • Acmeware and Avo Partner to Bring Real-Time Data Integration to MEDITECH Customers
  • New Analysis Reveals Most Patients Discontinue Weight Loss Drugs Within First Year
  • Preston Dermatology & Skin Surgery Center Wins Gold and Bronze in Prestigious Annual DIAMOND Awards
  • The Stork Foundation Announces 2025 Year-End Impact and Grant Awards Amid Rising National Demand
  • Japan's Patented "Hammock'n" Smartphone Band Targets Hand Fatigue From Long Phone Use
  • CCHR: Harvard Review Exposes Institutional Corruption in Global Mental Health
  • Global License Exclusive Secured for Emesyl OTC Nausea Relief, Expanding Multi-Product Growth Strategy for Caring Brands, Inc. (N A S D A Q: CABR)
  • American Laser Study Club Announces 2026 Kumar Patel Prize in Laser Surgery Recipients: Ann Bynum, DDS, and Boaz Man, DVM
  • Lineus Medical Completes UK Registration for SafeBreak® Vascular
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute